<HashMap><database>biostudies-literature</database><scores/><additional><submitter>McGurnaghan SJ</submitter><funding>Wellcome Trust</funding><pagination>82-93</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7832778</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>We aimed to ascertain the cumulative risk of fatal or critical care unit-treated COVID-19 in people with diabetes and compare it with that of people without diabetes, and to investigate risk factors for and build a cross-validated predictive model of fatal or critical care unit-treated COVID-19 among people with diabetes.&lt;h4>Methods&lt;/h4>In this cohort study, we captured the data encompassing the first wave of the pandemic in Scotland, from March 1, 2020, when the first case was identified, to July 31, 2020, when infection rates had dropped sufficiently that shielding measures were officially terminated. The participants were the total population of Scotland, including all people with diabetes who were alive 3 weeks before the start of the pandemic in Scotland (estimated </pubmed_abstract><journal>The lancet. Diabetes &amp; endocrinology</journal><pubmed_title>Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.</pubmed_title><pmcid>PMC7832778</pmcid><funding_grant_id>201492/Z/16/Z</funding_grant_id><pubmed_authors>McDonald E</pubmed_authors><pubmed_authors>Bailey D</pubmed_authors><pubmed_authors>Mellor J</pubmed_authors><pubmed_authors>Petrie J</pubmed_authors><pubmed_authors>Collier A</pubmed_authors><pubmed_authors>Purdie C</pubmed_authors><pubmed_authors>Carruthers J</pubmed_authors><pubmed_authors>Merrick A</pubmed_authors><pubmed_authors>Hatam S</pubmed_authors><pubmed_authors>Brownlie S</pubmed_authors><pubmed_authors>McAuley A</pubmed_authors><pubmed_authors>Murphy-Hall M</pubmed_authors><pubmed_authors>McAllister DA</pubmed_authors><pubmed_authors>Murray J</pubmed_authors><pubmed_authors>Scottish Diabetes Research Network Epidemiology Group</pubmed_authors><pubmed_authors>McKeigue PM</pubmed_authors><pubmed_authors>Gowans G</pubmed_authors><pubmed_authors>Colhoun HM</pubmed_authors><pubmed_authors>Gaffney A</pubmed_authors><pubmed_authors>Fischbacher C</pubmed_authors><pubmed_authors>Goldberg D</pubmed_authors><pubmed_authors>Smith-Palmer A</pubmed_authors><pubmed_authors>Gasiorowski A</pubmed_authors><pubmed_authors>Hall R</pubmed_authors><pubmed_authors>Sullivan C</pubmed_authors><pubmed_authors>McKnight J</pubmed_authors><pubmed_authors>Drennan G</pubmed_authors><pubmed_authors>McLeod A</pubmed_authors><pubmed_authors>Glass E</pubmed_authors><pubmed_authors>Kennedy S</pubmed_authors><pubmed_authors>McCrimmon R</pubmed_authors><pubmed_authors>Henderson D</pubmed_authors><pubmed_authors>McMenamin J</pubmed_authors><pubmed_authors>Young J</pubmed_authors><pubmed_authors>Colombo M</pubmed_authors><pubmed_authors>Kennon B</pubmed_authors><pubmed_authors>Paton M</pubmed_authors><pubmed_authors>Llano M</pubmed_authors><pubmed_authors>McArdle E</pubmed_authors><pubmed_authors>Wild SH</pubmed_authors><pubmed_authors>Heatlie K</pubmed_authors><pubmed_authors>Blackbourn LAK</pubmed_authors><pubmed_authors>McCoubrey J</pubmed_authors><pubmed_authors>Lone N</pubmed_authors><pubmed_authors>Sattar N</pubmed_authors><pubmed_authors>Weir A</pubmed_authors><pubmed_authors>Public Health Scotland COVID-19 Health Protection Study Group</pubmed_authors><pubmed_authors>Hutchinson S</pubmed_authors><pubmed_authors>McGurnaghan SJ</pubmed_authors><pubmed_authors>Milne A</pubmed_authors><pubmed_authors>Malcolm W</pubmed_authors><pubmed_authors>Whettlock A</pubmed_authors><pubmed_authors>Bishop J</pubmed_authors><pubmed_authors>Philip S</pubmed_authors><pubmed_authors>Hohn A</pubmed_authors><pubmed_authors>Caparrotta TM</pubmed_authors><pubmed_authors>O'Reilly JE</pubmed_authors><pubmed_authors>Lindsay R</pubmed_authors><pubmed_authors>Went A</pubmed_authors><pubmed_authors>Ramsey C</pubmed_authors><pubmed_authors>Robertson C</pubmed_authors><pubmed_authors>Butterly E</pubmed_authors><pubmed_authors>Jeyam A</pubmed_authors><pubmed_authors>Murdoch H</pubmed_authors><pubmed_authors>Reid M</pubmed_authors><pubmed_authors>Pearson E</pubmed_authors><pubmed_authors>Donaldson L</pubmed_authors><pubmed_authors>Reid G</pubmed_authors><pubmed_authors>Cameron R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland.</name><description>&lt;h4>Background&lt;/h4>We aimed to ascertain the cumulative risk of fatal or critical care unit-treated COVID-19 in people with diabetes and compare it with that of people without diabetes, and to investigate risk factors for and build a cross-validated predictive model of fatal or critical care unit-treated COVID-19 among people with diabetes.&lt;h4>Methods&lt;/h4>In this cohort study, we captured the data encompassing the first wave of the pandemic in Scotland, from March 1, 2020, when the first case was identified, to July 31, 2020, when infection rates had dropped sufficiently that shielding measures were officially terminated. The participants were the total population of Scotland, including all people with diabetes who were alive 3 weeks before the start of the pandemic in Scotland (estimated </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-26T06:31:06.541Z</modification><creation>2021-02-21T02:31:09Z</creation></dates><accession>S-EPMC7832778</accession><cross_references><pubmed>33357491</pubmed><doi>10.1016/S2213-8587(20)30405-8</doi></cross_references></HashMap>